A biotech powerhouse developing advanced therapy medicinal products (ATMPs) that drive progress in regenerative medicine and immunology
Levering allogeneic cells technologies, we provide safe, effective and affordable treatments for millions of patients worldwide. Through our open innovation model, we integrate the entire value chain, making us a one-stop partner to drive ATMP success from concept to commercialization. We cover the 3 types of ATMPs and the full spectrum of services needed to bring them to market.
The first pre-clinical research program exploring an allogeneic therapy with mesenchymal stem cells for androgenetic alopecia
Premium-quality manufacturing compliant with GMP standards, with distribution across Europe
We are supported by top-tier healthcare and technology investors who share our vision of becoming a global leader in advanced therapies.
